AboutUs Profile
Facilities > Baddi Facility

Baddi

This facility is dedicated to manufacturing Cephalosporins and its combination products. It has the capacity to manufacture Solid and Liquid dosage forms of Cephalosporins.

This facility houses a State-of-the-Art Pilot Plant for the manufacture of exhibit batches for Regulated Markets. This facility is approved by US-FDA and WHO-GMP. Currently caters to the needs of the Indian market.

Installed Capacities

Triple Shift Basis

750000

Oral Liquid -Bottles / per month

330M

Solid Dosage -Tablets / per month

750000

Solid Dosage -Dry Syrup Powder (Bottles) / per month

Accreditations

Plants Dosage Accreditations
Baddi     Oral Liquids
  • WHO-GMP
Tablets
  • US-FDA
  • WHO-GMP
Dry Syrup Powders
  • WHO-GMP
 
  • US-FDA
  • WHO-GMP
  • Yemen

 

Manufacturing Overview